These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20167540)

  • 1. Immunoglobulin class switch recombination deficiencies.
    Kracker S; Gardes P; Mazerolles F; Durandy A
    Clin Immunol; 2010 May; 135(2):193-203. PubMed ID: 20167540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects of class-switch recombination.
    Notarangelo LD; Lanzi G; Peron S; Durandy A
    J Allergy Clin Immunol; 2006 Apr; 117(4):855-64. PubMed ID: 16630945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.
    Péron S; Pan-Hammarström Q; Imai K; Du L; Taubenheim N; Sanal O; Marodi L; Bergelin-Besançon A; Benkerrou M; de Villartay JP; Fischer A; Revy P; Durandy A
    J Exp Med; 2007 May; 204(5):1207-16. PubMed ID: 17485519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin class-switch recombination deficiencies.
    Durandy A; Kracker S
    Arthritis Res Ther; 2012 Jul; 14(4):218. PubMed ID: 22894609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes).
    Durandy A; Revy P; Fischer A
    Adv Immunol; 2004; 82():295-330. PubMed ID: 14975260
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
    Durandy A
    Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies.
    Luo Z; Ronai D; Scharff MD
    J Allergy Clin Immunol; 2004 Oct; 114(4):726-35; quiz 736. PubMed ID: 15480307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodeficiencies due to defects of class-switch recombination.
    Notarangelo LD; Lanzi G; Toniati P; Giliani S
    Immunol Res; 2007; 38(1-3):68-77. PubMed ID: 17917012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation.
    Ehrenstein MR; Neuberger MS
    EMBO J; 1999 Jun; 18(12):3484-90. PubMed ID: 10369687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Somatic Hypermutation and Class Switch Recombination.
    Methot SP; Di Noia JM
    Adv Immunol; 2017; 133():37-87. PubMed ID: 28215280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyper-immunoglobulin-M syndromes caused by an intrinsic B cell defect.
    Durandy A; Revy P; Fischer A
    Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):421-5. PubMed ID: 14612665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
    Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
    J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice.
    Bardwell PD; Woo CJ; Wei K; Li Z; Martin A; Sack SZ; Parris T; Edelmann W; Scharff MD
    Nat Immunol; 2004 Feb; 5(2):224-9. PubMed ID: 14716311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyper-IgM syndromes.
    Durandy A; Peron S; Fischer A
    Curr Opin Rheumatol; 2006 Jul; 18(4):369-76. PubMed ID: 16763457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited defects of immunoglobulin class switch recombination.
    Kracker S; Gardës P; Durandy A
    Adv Exp Med Biol; 2010; 685():166-74. PubMed ID: 20687504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
    Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
    Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of AID-mediated sequence diversification by cis-acting determinants.
    Yang SY; Schatz DG
    Adv Immunol; 2007; 94():109-25. PubMed ID: 17560273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for Msh6 but not Msh3 in somatic hypermutation and class switch recombination.
    Martomo SA; Yang WW; Gearhart PJ
    J Exp Med; 2004 Jul; 200(1):61-8. PubMed ID: 15238605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apex2 is required for efficient somatic hypermutation but not for class switch recombination of immunoglobulin genes.
    Sabouri Z; Okazaki IM; Shinkura R; Begum N; Nagaoka H; Tsuchimoto D; Nakabeppu Y; Honjo T
    Int Immunol; 2009 Aug; 21(8):947-55. PubMed ID: 19556307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.